Guardant Health, Inc. (GH)

Nasdaq · Healthcare · Diagnostics & Research
$145.83+0.16%As of 2026-11-22 · USD
Last session low $141.00Last session high $148.26
52-week low $74.5552-week high $191.05
Market cap
$19.73B
Sector
Healthcare

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)37.4In the neutral range (30 to 70)
MACD (12, 26, 9)-6.51Below its signal line (-4.91); histogram -1.60
Bollinger %B (20, 2)23%Inside the bands (133.15 to 188.50)
SMA 20160.82Price is 9.3% below
SMA 50167.10Price is 12.7% below
SMA 200133.68Price is 9.1% above
ATR (20)6.32% of priceAverage true range per day
52-week position61%In the middle of the 74.55 to 191.05 range

About Guardant Health, Inc.

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally.

Insider filings, 90 daysNo purchases and 7 sales (about $3.4M).
Latest fiscal yearEnded 2025-12-31: revenue of $982.02M and an operating margin of -44.5%.

More in Diagnostics & Research